InvestorsHub Logo
Followers 13
Posts 1599
Boards Moderated 0
Alias Born 12/14/2016

Re: longboarder7892 post# 142502

Wednesday, 07/14/2021 9:49:53 AM

Wednesday, July 14, 2021 9:49:53 AM

Post# of 144814
"Nasdaq is requiring the Company to trade above $4.00 for 10 trading days before we can uplist.”

This is a true statement. But it is SO misleading to shareholders.

I spent two hours going over the Nasdaq requirements in specificity.

There is no way this company qualifies for the Nasdaq. PharmaCyte does not meet the requirements.

Just trading over $4.00 for ten days is one requirement. The company has had 0 revenue for a long time.

Their assets are small.

The Nasdaq requires strong management and sound reputation. I will certainly come back and eat crow if I am wrong but the way I understand it , No way does PMCB qualify for the Nasdaq and it's not even close.

I believe management is getting bolder in misleading shareholders when they say we are going to be listed on the Nasdaq.

This is all just one educated persons opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News